Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Huirong Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2113-7260; OpenAlex author ID A5100771600. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysis. Last author DOI 10.1038/s41698-025-01087-1↗
  2. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort Study. Co-author DOI 10.1097/mpa.0000000000001851↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yubo Jiang · 1 shared paper, 2025 · strength 0.21
  2. Zuoxing Niu · 1 shared paper, 2025 · strength 0.21
  3. Yuliang Li · 1 shared paper, 2021 · strength 0.10
  4. Wujie Wang · 1 shared paper, 2021 · strength 0.10
  5. Xiaoping Zhang · 1 shared paper, 2021 · strength 0.10
  6. Jun Chen · 1 shared paper, 2021 · strength 0.10
  7. Shilong Han · 1 shared paper, 2021 · strength 0.10
  8. Maoquan Li · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.